Dear Researchers,

The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Miklóssy Gabriella

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2004-2012

2012

Tőzsér, J., Berta, A., Csutak, A., Miklóssy, G.: Use of Urokinase Type Plasminogen Activator Inhibitors for the Treatment of Corneal Disorders.

2011

Tőzsér, J., Berta, A., Csutak, A., Miklóssy, G.: Use of Urokinase Type Plasminogen Activator Inhibitors for the Treatment of Corneal Disorders.

DEA

2009

Tőzsér, J., Miklóssy, G., Berta, A., Csutak, A.: Rekombináns plazminogén aktivátorinhibitor-2 fúziós fehérje előállítása és szemcseppként történő alkalmazása korneális szaruhártya fekélyek gyógyításában = Process for producing plasminogen activator inhibitor-2 fusion protein and use thereof as eye drop for treating corneal ulcer.

DEA

2008

Eizert, E. H., Bander, P., Bagossi, P., Sperka, T., Miklóssy, G., Boross, P., Weber, I. T., Tőzsér, J.: Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site.
J. Virol. 82 (20), 10111-10117, 2008.

doi DEA

Journal metrics:

D1 Immunology

D1 Insect Science

D1 Microbiology

D1 Virology

Benkő, S., Tőzsér, J., Miklóssy, G., Varga, A., Kádas, J., Csutak, A., Berta, A., Rajnavölgyi, É.: Constitutive and UV-B modulated transcription of Nod-like receptors and their functional partners in human corneal epithelial cells.
Mol. Vis. 14 (187-188), 1575-1583, 2008.

DEA

Journal metrics:

Q1 Ophthalmology

Miklóssy, G., Tőzsér, J., Kádas, J., Ishima, R., Louis, J. M., Bagossi, P.: Novel macromolecular inhibitors of human immunodeficiency virus-l protease.
Protein Eng. Des. Sel. 21 (7), 453-461, 2008.

doi DEA

Journal metrics:

Q1 Biochemistry

Q1 Bioengineering

Q1 Biotechnology

Q2 Molecular Biology

2007

Sperka, T., Miklóssy, G., Tie, Y., Bagossi, P., Zahuczky, G., Boross, P., Matúz, K., Harrison, R. W., Weber, I. T., Tőzsér, J.: Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus protease.
J. Gen. Virol. 88 (7), 2052-2063, 2007.

doi DEA

Journal metrics:

Q1 Virology

2006

Fehér, A., Boross, P., Sperka, T., Miklóssy, G., Kádas, J., Bagossi, P., Oroszlan, S., Weber, I. T., Tőzsér, J.: Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease.
J. Gen. Virol. 87 (5), 1321-1330, 2006.

doi DEA

Journal metrics:

Q1 Virology

2005

Bagossi, P., Sperka, T., Fehér, A., Kádas, J., Zahuczky, G., Miklóssy, G., Boross, P., Tőzsér, J.: Amino Acid Preferences for a Critical Substrate Binding Subsite of Retroviral Proteases in Type 1 Cleavage Sites.
J. Virol. 79 (7), 4213-4218, 2005.

doi DEA

Journal metrics:

D1 Immunology

D1 Insect Science

D1 Microbiology

D1 Virology

2004

10.

Bagossi, P., Kádas, J., Miklóssy, G., Boross, P., Weber, I. T., Tőzsér, J.: Development of a microtiter plate fluorescent assay for inhibition studies on the HTLV-1 and HIV-1 proteinases.
J. Virol. Methods. 119 (2), 87-93, 2004.

doi DEA

Journal metrics:

Q2 Virology

11.

Kádas, J., Weber, I. T., Bagossi, P., Miklóssy, G., Boross, P., Oroszlan, S., Tőzsér, J.: Narrow Substrate Specificity and Sensitivity toward Ligand-binding Site Mutations of Human T-cell Leukemia Virus Type 1 Protease.
J. Biol. Chem. 279 (26), 27148-27157, 2004.

doi DEA

Journal metrics:

D1 Biochemistry

D1 Cell Biology

D1 Molecular Biology